Citigroup’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-495,400
Closed -$44.1M 7654
2017
Q1
$44.1M Buy
495,400
+493,200
+22,418% +$40.6M 0.04% 407
2016
Q4
$156K Sell
2,200
-600
-21% -$44.7K ﹤0.01% 5485
2016
Q3
$221K Sell
2,800
-20,600
-88% -$1.76M ﹤0.01% 4574
2016
Q2
$2.12M Buy
23,400
+19,100
+444% +$1.62M ﹤0.01% 2295
2016
Q1
$365K Buy
4,300
+1,600
+59% +$119K ﹤0.01% 4485
2015
Q4
$213K Buy
2,700
+2,400
+800% +$189K ﹤0.01% 4692
2015
Q3
$21K Buy
+300
New +$24.7K ﹤0.01% 6018
2014
Q4
Sell
-28,000
Closed -$2.69M 7487
2014
Q3
$2.69M Sell
28,000
-12,900
-32% -$1.22M ﹤0.01% 2323
2014
Q2
$3.81M Buy
+40,900
New +$3.58M ﹤0.01% 2008
2013
Q3
Sell
-16,800
Closed -$1.33M 7132
2013
Q2
$1.33M Buy
+16,800
New +$1.35M ﹤0.01% 2670

Other funds holding MJN

Citigroup's MJN Position: Q2 2017 in Review

Citigroup sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,117,834 shares — an estimated $99.6M sold.

Citigroup first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $99.6M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Citigroup reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Citigroup sold 1,117,834 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $99.6M.
  • Citigroup first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Citigroup's Mead Johnson Nutrition Company position peaked at $99.6M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.